Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors

NCT00138216 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00138216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00138216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2005
Completion date
January 31, 2011
Enrollment
42 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, unspecified childhood solid tumor, protocol specific